Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma
about
High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancermiR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal TransitionβIII-Tubulin: biomarker of taxane resistance or drug target?Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growthMicrotubules and their role in cellular stress in cancerDrug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines.A target based approach identifies genomic predictors of breast cancer patient response to chemotherapy.Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy.Rsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma.The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancerOverexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer.Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.6-Methoxy Podophyllotoxin Induces Apoptosis via Inhibition of TUBB3 and TOPIIA Gene Expressions in 5637 and K562 Cancer Cell Lines.Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin.The role of Tau protein in resistance to paclitaxel.Stathmin: a protein with many tasks. New biomarker and potential target in cancer.Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?Tubulin: an example of targeted chemotherapy.The Elephant in the Room: The Role of Microtubules in Cancer.High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy ResistanceEsophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway.Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance
P2860
Q27851983-EB45A81F-B93E-4535-BB2D-46AF59BFE019Q28071987-1F4C67FC-22D0-4357-8AEE-FB1963F18C7DQ28284878-36945D8A-6D96-4B33-8DFA-B0E394F4982BQ28484303-BC5BB464-59B6-43A9-ABC2-AE3A5F9D0602Q33770927-75A55457-864B-4C4F-A2F5-1DBED8A3A174Q34104738-51D97D2D-FED4-463F-9B6B-96CC715F584DQ34266467-D65E0E95-1636-4432-9F65-005677232E75Q34428153-78994B54-B71C-4055-A2A6-D9EB65B91032Q34643587-38F558AE-CCB8-414D-A02C-6580F21D43ADQ35214846-06D8811F-590B-4C08-9324-B68E4CB9E6B1Q35703969-A56894B5-1D90-41AB-B94B-BDE570FFBEF1Q36080919-826BBDE3-B571-4262-ADF5-156AC25BD82DQ36148796-1543B92F-8EF6-4D6E-8ED4-63E829AFA2A4Q36608043-B8B1CFA2-5FB5-4DC7-954C-7ABF386D20CCQ37570220-C26656EA-1906-45E2-AE23-819307C127B5Q37895519-F5C6895F-DB60-479B-AD8A-83BBC5712193Q37942978-2382D90B-18FA-4607-B347-AF6207AD6722Q38069185-147E4B09-B2FC-49BD-8D15-FE49798DF80DQ38086872-CD709D5F-D964-4E2C-8FC3-7B5CDFC7D943Q38672574-DF7A9627-A5CB-42F7-8179-6FC51C6D44A3Q38770214-34E5993C-5C33-4E21-B55E-B6386D5D7FB9Q39414846-4204C03F-0765-4302-8A81-D132A3DC5483Q53681641-C20844FA-D789-4049-9B52-7FAD8CF57EF6Q58766772-A8A54281-EE9F-4081-857C-392C0BEC69D3
P2860
Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Overexpression of class III be ...... rian clear cell adenocarcinoma
@ast
Overexpression of class III be ...... rian clear cell adenocarcinoma
@en
Overexpression of class III be ...... rian clear cell adenocarcinoma
@nl
type
label
Overexpression of class III be ...... rian clear cell adenocarcinoma
@ast
Overexpression of class III be ...... rian clear cell adenocarcinoma
@en
Overexpression of class III be ...... rian clear cell adenocarcinoma
@nl
prefLabel
Overexpression of class III be ...... rian clear cell adenocarcinoma
@ast
Overexpression of class III be ...... rian clear cell adenocarcinoma
@en
Overexpression of class III be ...... rian clear cell adenocarcinoma
@nl
P2093
P921
P3181
P1476
Overexpression of class III be ...... rian clear cell adenocarcinoma
@en
P2093
Ken-ichi Taguchi
Masazumi Tsuneyoshi
Mayumi Ono
Michihiko Kuwano
Nao Suzuki
Satoshi Hattori
Shinji Oie
Suminori Kono
Takashi Yanagawa
Yoshihiro Ohishi
P304
P3181
P356
10.1158/1078-0432.CCR-08-1274
P407
P50
P577
2009-02-15T00:00:00Z